Orexo AB (publ)

LSE:0H19 Stock Report

Market Cap: SEK 629.4m

Orexo Management

Management criteria checks 2/4

Orexo's CEO is Nikolaj Sorensen, appointed in Feb 2013, has a tenure of 11.92 years. total yearly compensation is SEK6.12M, comprised of 59.5% salary and 40.5% bonuses, including company stock and options. directly owns 0.52% of the company’s shares, worth SEK3.27M. The average tenure of the management team and the board of directors is 6 years and 3.8 years respectively.

Key information

Nikolaj Sorensen

Chief executive officer

SEK 6.1m

Total compensation

CEO salary percentage59.5%
CEO tenure11.9yrs
CEO ownership0.5%
Management average tenure6yrs
Board average tenure3.8yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Nikolaj Sorensen's remuneration changed compared to Orexo's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2024n/an/a

-SEK 105m

Jun 30 2024n/an/a

-SEK 97m

Mar 31 2024n/an/a

-SEK 73m

Dec 31 2023SEK 6mSEK 4m

-SEK 128m

Sep 30 2023n/an/a

-SEK 201m

Jun 30 2023n/an/a

-SEK 195m

Mar 31 2023n/an/a

-SEK 218m

Dec 31 2022SEK 6mSEK 4m

-SEK 178m

Sep 30 2022n/an/a

-SEK 152m

Jun 30 2022n/an/a

-SEK 177m

Mar 31 2022n/an/a

-SEK 216m

Dec 31 2021SEK 10mSEK 4m

-SEK 223m

Sep 30 2021n/an/a

-SEK 207m

Jun 30 2021n/an/a

-SEK 240m

Mar 31 2021n/an/a

-SEK 198m

Dec 31 2020SEK 9mSEK 3m

-SEK 84m

Sep 30 2020n/an/a

SEK 4m

Jun 30 2020n/an/a

SEK 201m

Mar 31 2020n/an/a

SEK 288m

Dec 31 2019SEK 6mSEK 3m

SEK 219m

Sep 30 2019n/an/a

SEK 232m

Jun 30 2019n/an/a

SEK 182m

Mar 31 2019n/an/a

SEK 178m

Dec 31 2018SEK 5mSEK 3m

SEK 138m

Compensation vs Market: Nikolaj's total compensation ($USD548.91K) is above average for companies of similar size in the UK market ($USD352.54K).

Compensation vs Earnings: Nikolaj's compensation has increased whilst the company is unprofitable.

CEO

Nikolaj Sorensen (52 yo)

11.9yrs

Tenure

SEK 6,118,000

Compensation

Mr. Nikolaj Sørensen serves as Independent Director at Bioservo Technologies AB (publ) since May 6, 2019. He is Director at Gesynta Pharma AB. He has been the Chief Executive Officer of Orexo AB since Febr...

Leadership Team

NamePositionTenureCompensationOwnership
Nikolaj Sorensen
President & CEO11.9yrsSEK 6.12m0.52%
SEK 3.3m
Fredrik Jarrsten
Executive VP & CFO2.4yrsno data0.076%
SEK 477.7k
Cecilia Coupland
Senior VP & Head of Operations6yrsno data0.042%
SEK 262.4k
Lena Wange
Investor Relations & Communications Directorno datano datano data
Robert Ronn
Senior VP and Head of R&D6yrsno data0.059%
SEK 369.9k
Edward Kim
Chief Medical Officer2.3yrsno datano data
Robert Deluca
President of Orexo US Inc12yrsno data0.051%
SEK 320.7k
Jesper Lind
Advisorno datano datano data

6.0yrs

Average Tenure

54.5yo

Average Age

Experienced Management: 0H19's management team is seasoned and experienced (6 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
George Wilkinson
Independent Director5.8yrsSEK 400.00k0.056%
SEK 350.2k
James Noble
Independent Chairman of the Board4.8yrsSEK 1.50m0.19%
SEK 1.2m
Staffan Lindstrand
Independent Director23yrsSEK 450.00k0.099%
SEK 622.8k
Christine Rankin
Independent Director2.8yrsSEK 550.00k0.023%
SEK 144.6k
Robin Evers
Independent Director1.3yrsSEK 50.00kno data
Friedrich von Und halbach
Directorless than a yearno datano data

3.8yrs

Average Tenure

62yo

Average Age

Experienced Board: 0H19's board of directors are considered experienced (3.8 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/02 03:11
End of Day Share Price 2025/01/02 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Orexo AB (publ) is covered by 12 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Sten GustafssonABG Sundal Collier
Klas PalinCarnegie Commissioned Research
Kristofer Liljeberg-SvenssonCarnegie Investment Bank AB